【2h】

Regulation of DREAM Expression by Group I mGluR

机译:I组mGluR对DREAM表达的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DREAM (downstream regulatory element antagonistic modulator) is a calcium-binding protein that regulates dynorphin expression, promotes potassium channel surface expression, and enhances presenilin processing in an expression level-dependent manner. However, no molecular mechanism has yet explained how protein levels of DREAM are regulated. Here we identified group I mGluR (mGluR1/5) as a positive regulator of DREAM protein expression. Overexpression of mGluR1/5 increased the cellular level of DREAM. Up-regulation of DREAM resulted in increased DREAM protein in both the nucleus and cytoplasm, where the protein acts as a transcriptional repressor and a modulator of its interacting proteins, respectively. DHPG (3,5-dihydroxyphenylglycine), a group I mGluR agonist, also up-regulated DREAM expression in cortical neurons. These results suggest that group I mGluR is the first identified receptor that may regulate DREAM activity in neurons.
机译:DREAM(下游调节元件拮抗调节剂)是一种钙结合蛋白,可调节强啡肽表达,促进钾通道表面表达,并以表达水平依赖性方式增强早老素的加工。然而,尚无分子机制解释DREAM的蛋白质水平如何被调节。在这里,我们将I组mGluR(mGluR1 / 5)识别为DREAM蛋白表达的正调节剂。 mGluR1 / 5的过表达增加了DREAM的细胞水平。 DREAM的上调导致细胞核和细胞质中的DREAM蛋白增加,其中该蛋白分别充当其相互作用蛋白的转录阻遏物和调节剂。 DHPG(3,5-二羟基苯基甘氨酸),第I组mGluR激动剂,也上调了皮质神经元中DREAM的表达。这些结果表明,第I组mGluR是第一个可以调节神经元DREAM活性的受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号